Concepedia

Formulation Feasibility

Formulation Feasibility is a preclinical development assessment that evaluates the potential to develop a stable, bioavailable, and manufacturable dosage form of a drug candidate, considering its physicochemical properties, intended route of administration, and therapeutic requirements.

14

Publications

758

Citations

48

Authors

20

Institutions

Publications per year

2017–2026

3

Parents

Publications

14

The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development

James Butler, Jennifer Dressman · Journal of Pharmaceutical Sciences · 2010 · 412 citations · Full text

, , +16

Recent advances and novel strategies in pre-clinical formulation development: An overview

Amit Shah, Sunil A. Agnihotri · Journal of Controlled Release · 2011 · 66 citations

, , +12

Experimental design for a pharmaceutical formulation: optimisation and robustness

Barbara Campisi, Daniela Chicco, D. Vojnović et al. · Journal of Pharmaceutical and Biomedical Analysis · 1998 · 41 citations

, , +14

Design and Formulation of Mebeverine HCl Semisolid Formulations for Intraorally Administration

Esra Baloğlu, Sinem Yaprak Karavana, Ismail Yuksel Hyusein et al. · AAPS PharmSciTech · 2010 · 39 citations · Full text

, , +14

Development and optimization of pharmaceutical formulations using a simplex lattice design

R. M. Huisman, H. V. van Kamp, J. W. Weyland et al. · Pharmacy World & Science · 1984 · 37 citations

, , +10

1–5 of 14

Authors

48

  1. BT
    Brendan T. Griffin

    University College Cork, Ireland

    1 publications · 32 citations

    1

    h-index

  2. KR
    Kavitha Ranganathan

    University of Michigan, United States

    1 publications · 14 citations

    1

    h-index

  3. RM
    R. M. Huisman

    University of Groningen, Netherlands

    1 publications · 37 citations

    1

    h-index

  4. TA
    Tom Alfredson

    Roche (United States), United States

    1 publications · 15 citations

    1

    h-index

  5. DR
    D.J. Rhodes

    Ecologie microbienne, France

    1 publications · 16 citations

    1

    h-index

1–5 of 48

Institutions

20

  1. Janssen (Belgium)

    Beerse, Belgium

    1 h-index

    1 publications

    32 citations

  2. GlaxoSmithKline (United Kingdom)

    London, United Kingdom

    1 h-index

    1 publications

    412 citations

  3. Therapeutics Systems Research Laboratories (United States)

    Ann Arbor, United States

    1 h-index

    3 publications

    42 citations

  4. FHNW University of Applied Sciences and Arts Northwestern Switzerland

    Windisch, Switzerland

    1 h-index

    2 publications

    64 citations

  5. Syngenta (United Kingdom)

    Fulbourn, United Kingdom

    1 h-index

    1 publications

    17 citations

  6. University of Trieste

    Trieste, Italy

    1 h-index

    3 publications

    123 citations

  7. Neurocrine Biosciences (United States)

    San Diego, United States

    1 h-index

    2 publications

    44 citations

  8. University of Michigan

    Ann Arbor, United States

    1 h-index

    8 publications

    112 citations

1–8 of 20

Venues

  1. Journal of Pharmaceutical Sciences

    3 publications · 460 citations

    3

    h-index

  2. 1

    h-index

  3. Aspects of applied biology

    1 publications · 16 citations

    1

    h-index

  4. AAPS PharmSciTech

    1 publications · 39 citations

    1

    h-index

  5. Pharmaceutical Research

    1 publications · 14 citations

    1

    h-index

1–5